SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-18-002991
Filing Date
2018-11-19
Accepted
2018-11-19 16:05:41
Documents
3
Period of Report
2018-11-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1822302.htm 8-K 25817
2 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 11939
3 image0.jpg GRAPHIC 8283
  Complete submission text file 0001178913-18-002991.txt   50627
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36621 | Film No.: 181192540
SIC: 2833 Medicinal Chemicals & Botanical Products